Lag time for diagnosis and treatment in 1120 retinoblastoma children: Analysis from InPOG-RB-19-01
- PMID: 40719713
- DOI: 10.4103/IJO.IJO_3031_24
Lag time for diagnosis and treatment in 1120 retinoblastoma children: Analysis from InPOG-RB-19-01
Abstract
Setting: Increased lag time for diagnosis and treatment is a key determinant of adverse retinoblastoma (RB) outcomes. Analysis from INPHOG-RB-19-01, a prospective, multicentric study of newly diagnosed RB with regard to lag time and its correlation with various variables, is presented.
Patient or study population: All newly diagnosed RB patients treated at the participating centers during the study period were enrolled.
Observation procedure: Lag time was subdivided into parent-lag time (symptom onset to first consult) and system-lag time (including diagnosis lag time, defined as first consult to diagnosis, and treatment lag time, defined as diagnosis to treatment initiation.). Multivariate logistic regression analysis was used to assess factors predictive of increased lag time.
Main outcome measures: In all, 1120 patients from 20 centers were enrolled over a 36-month period. Extraocular or metastatic disease was present in 25.2% of patients at diagnosis. The mean lag time from symptom onset to treatment initiation was 4.2 months (range 0.5-61.6 months). Parental, diagnosis, and treatment lag time contributed to 44%, 26%, and 31% of the total lag time, respectively. Increased lag time had significant correlation with the stage at presentation (P < 0.05), lower socio-economic status (P = 0.006), increased distance from treating center (P = 0.001), younger maternal age at pregnancy (P < 0.05), family history of cancer (P = 0.031), and first consultation with a non-specialist (P = 0.001), and showed a negative correlation with improved maternal education. Parental lag time is the major contributor to the cascading delay in RB diagnosis and treatment initiation. Efforts for earlier diagnosis, therefore, need to be directed towards community awareness and routine screening during contact with healthcare professionals, such as at immunization.
Keywords: Extraocular; lag time; parental lag time; retinoblastoma; time to diagnosis.
Copyright © 2025 Indian Journal of Ophthalmology.
Similar articles
-
Lag Time Between Onset of First Symptom and Treatment of Retinoblastoma: Outcomes at Three Years from Recruitment.Semin Ophthalmol. 2025 Aug;40(6):551-557. doi: 10.1080/08820538.2025.2491004. Epub 2025 Apr 12. Semin Ophthalmol. 2025. PMID: 40219812
-
Afghanistan-Pakistan retinoblastoma "Silk Road" referral pathway.Eye (Lond). 2025 Aug;39(11):2164-2168. doi: 10.1038/s41433-025-03823-0. Epub 2025 May 3. Eye (Lond). 2025. PMID: 40319173
-
Second Malignant Neoplasms in Long-term Retinoblastoma Survivors: Retrospective Cohort Study of 491 Patients in Turkey.J Pediatr Hematol Oncol. 2025 Jul 1;47(5):e161-e167. doi: 10.1097/MPH.0000000000003039. Epub 2025 Apr 21. J Pediatr Hematol Oncol. 2025. PMID: 40262045
-
Survival outcomes and globe salvage rates of retinoblastoma in India - A systematic review.Indian J Ophthalmol. 2025 Aug 1;73(8):1116-1123. doi: 10.4103/IJO.IJO_3033_24. Epub 2025 Jul 28. Indian J Ophthalmol. 2025. PMID: 40719712
-
Does the Clinical Presentation of Secondary Osteosarcoma in Patients Who Survive Retinoblastoma Differ From That of Conventional Osteosarcoma and How Do We Detect Them?Clin Orthop Relat Res. 2023 Nov 1;481(11):2154-2163. doi: 10.1097/CORR.0000000000002667. Epub 2023 May 5. Clin Orthop Relat Res. 2023. PMID: 37145140 Free PMC article. Review.
References
-
- Sanders BM, Draper GJ, Kingston JE. Retinoblastoma in Great Britain 1969–1980: Incidence, treatment and survival. Br J Ophthalmol 1988;72:576–83.
-
- Abramson DH, Niksarli K, Ellsworth RM, Servodidio CA. Changing trends in the management of retinoblastoma 1951–1965 vs 1966–1980. J Pediatr Ophthalmol Strabismus 1994;31:32–7.
-
- Leal-Leal C, Flores-Rojo M, Medina-Sanson A, Cerecedo-Díaz F, Sánchez-Félix S, González-Ramella O, et al. A multi-centre report from the Mexican retinoblastoma group. Br J Ophthalmol 2004;88:1074–7.
-
- Kao LY, Su WW, Lin YW. Retinoblastoma in Taiwan: Survival and clinical characteristics 1978–2000. Jpn J Ophthalmol 2002;46:577–80.
-
- Badhu B, Sah SP, Thakur SK, Dulal S, Kumar S, Sood A, et al. Clinical presentation of retinoblastoma in Eastern Nepal. Clin Exp Ophthalmol 2005;33:386–9.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources